Related Experiment Video
Updated: Jul 7, 2025
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Mitochondrial damage-associated molecular patterns in chronic obstructive pulmonary disease: Pathogenetic mechanism
Yongchun Shen1, Lei Chen1, Jun Chen1
1Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University and Division of Pulmonary Diseases, State Key Laboratory of Biotherapy of China, Chengdu 610041, Sichuan Province, China.
Abstract:
Chronic obstructive pulmonary disease (COPD) is a common inflammatory airway disease characterized by enhanced inflammation. Recent studies suggest that mitochondrial damage-associated molecular patterns (DAMPs) may play an important role in the regulation of inflammation and are involved in a serial of inflammatory diseases, and they may also be involved in COPD. This review highlights the potential role of mitochondrial DAMPs during COPD pathogenesis and discusses the therapeutic potential of targeting mitochondrial DAMPs and their related signaling pathways and receptors for COPD. Research progress on mitochondrial DAMPs may enhance our understanding of COPD inflammation and provide novel therapeutic targets.
Insights
Mitochondrial damage-associated molecular patterns (DAMPs) are implicated in chronic obstructive pulmonary disease (COPD) inflammation. Targeting these DAMPs and their pathways offers potential new treatments for COPD.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cell Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is a prevalent inflammatory airway disease.
- Enhanced inflammation is a key characteristic of COPD pathogenesis.
- Mitochondrial damage-associated molecular patterns (DAMPs) are increasingly recognized for their role in inflammatory processes.
Purpose of the Study:
- To review the potential role of mitochondrial DAMPs in COPD.
- To discuss therapeutic strategies targeting mitochondrial DAMPs for COPD treatment.
- To explore novel therapeutic targets based on mitochondrial DAMPs research.
Main Methods:
- Literature review of recent studies on mitochondrial DAMPs and inflammation.
- Analysis of the involvement of mitochondrial DAMPs in COPD pathogenesis.
- Discussion of signaling pathways and receptors associated with mitochondrial DAMPs.
Main Results:
- Mitochondrial DAMPs are potentially involved in regulating inflammation in COPD.
- These molecules may play a significant role in the development of COPD.
- Targeting mitochondrial DAMPs presents a promising therapeutic avenue.
Conclusions:
- Mitochondrial DAMPs are crucial mediators in COPD inflammation.
- Targeting mitochondrial DAMPs and related pathways offers novel therapeutic potential for COPD.
- Further research into mitochondrial DAMPs can advance COPD understanding and treatment.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: